<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05904055002871</udiDi>
    <basicUdiDi>5904055001KQ3</basicUdiDi>
    <tradeName>ULGIX WZDĘCIA MAX</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.</manufacturerName>
    <manufacturerSrn>PL-MF-000009264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-04T19:50:10.749Z</lastUpdated>
  </row>
  <row>
    <udiDi>05904055002888</udiDi>
    <basicUdiDi>5904055001KQ3</basicUdiDi>
    <tradeName>ULGIX WZDĘCIA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.</manufacturerName>
    <manufacturerSrn>PL-MF-000009264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>_</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-04T19:50:10.723Z</lastUpdated>
  </row>
  <row>
    <udiDi>05904055002895</udiDi>
    <basicUdiDi>5904055001KQ3</basicUdiDi>
    <tradeName>ULGIX WZDĘCIA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.</manufacturerName>
    <manufacturerSrn>PL-MF-000009264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>_</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-04T19:50:10.696Z</lastUpdated>
  </row>
  <row>
    <udiDi>05904055002901</udiDi>
    <basicUdiDi>5904055001KQ3</basicUdiDi>
    <tradeName>ULGIX WZDĘCIA</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.</manufacturerName>
    <manufacturerSrn>PL-MF-000009264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-04T19:50:10.672Z</lastUpdated>
  </row>
  <row>
    <udiDi>05904055002918</udiDi>
    <basicUdiDi>5904055001KQ3</basicUdiDi>
    <tradeName>ULGIX WZDĘCIA MAX</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.</manufacturerName>
    <manufacturerSrn>PL-MF-000009264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-04T19:50:10.650Z</lastUpdated>
  </row>
  <row>
    <udiDi>05904055004226</udiDi>
    <basicUdiDi>5904055001KQ3</basicUdiDi>
    <tradeName>ULGIX USG</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.</manufacturerName>
    <manufacturerSrn>PL-MF-000009264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-04T19:50:10.613Z</lastUpdated>
  </row>
  <row>
    <udiDi>05904055004233</udiDi>
    <basicUdiDi>5904055001KQ3</basicUdiDi>
    <tradeName>ULGIX USG</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.</manufacturerName>
    <manufacturerSrn>PL-MF-000009264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-04T19:50:10.584Z</lastUpdated>
  </row>
  <row>
    <udiDi>05904055006169</udiDi>
    <basicUdiDi>5904055001KQ3</basicUdiDi>
    <tradeName>Salvit Gastricon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.</manufacturerName>
    <manufacturerSrn>PL-MF-000009264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Croatia</placedOnMarketCountry>
    <lastUpdated>2026-07-04T19:50:10.530Z</lastUpdated>
  </row>
  <row>
    <udiDi>05904055006176</udiDi>
    <basicUdiDi>5904055001KQ3</basicUdiDi>
    <tradeName>Salvit Gastricon</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - Lek S.A.</manufacturerName>
    <manufacturerSrn>PL-MF-000009264</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>ORALLY ADMINISTERED DEVICES FOR THE THERAPY OF GASTRO-INTESTINAL DISORDERS</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>-</reference>
    <placedOnMarketCountry>Croatia</placedOnMarketCountry>
    <lastUpdated>2026-07-04T19:50:10.498Z</lastUpdated>
  </row>
</eudamedExport>